Proteoglycan degrading mutants for treatment of CNS

Details for Australian Patent Application No. 2009251124 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Roy, Gargi; D'Souza, Rohini; Caggiano, Anthony O.; Gruskin, Elliott A.

Agent Pizzeys

Pub. Number AU-A-2009251124

Parent 2004247026

Filing date 23 December 2009

Wipo publication date 21 January 2010

International Classifications

C12N 15/60 (2006.01) Mutation or genetic engineering - Lyases (4)

A61K 31/00 (2006.01)

A61K 38/51 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

21 January 2010 Application Open to Public Inspection

  Published as AU-A-2009251124

21 January 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009251125-Water Collection Apparatus and Method

2009251123-Methods and apparatus for generating graphical and media displays at a client